According to a new report by Polaris Market Research, the global cannabis pharmaceuticals market was valued at USD 5.30 billion in 2024 and is projected to reach USD 357.96 billion by 2034, expanding at a CAGR of 52.4% over the forecast period. Growth is underpinned by rising acceptance of medical cannabis, expanding availability of non-psychoactive CBD-based therapies, and...